Shahkaar Aziz

University of Leeds — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index5.7kcitations33works260.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

vaccines and immunoinformatics approaches(8), Climate Change and Health Impacts(5), Monoclonal and Polyclonal Antibodies Research(4), Global Public Health Policies and Epidemiology(4), Obesity, Physical Activity, Diet(3)

Publications28 total

Design of a multi-epitope vaccine against intestinal parasites associated with colorectal cancer using immunoinformatics approaches
Scientific Reports·2025· 1 citedOpen Access
Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
The Lancet Child & Adolescent Health·2025Open Access
The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
The Lancet Public Health·2025· 7 citedOpen Access
The burden of diseases, injuries, and risk factors by voivodship in Poland, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Regional Health - Europe·2025· 1 citedOpen Access
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Global Health·2025· 31 citedOpen Access
Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Global Health·2025· 17 citedOpen Access
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
JAMA Neurology·2025· 15 citedOpen Access
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
The Lancet Respiratory Medicine·2025· 85 cited
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Public Health·2025· 123 citedOpen Access
Exploring natural compounds and synthetic derivatives as potential inhibitors of SARS-CoV-2 PLpro: a computational approach with enzyme inhibition and cytotoxicity assessment
Journal of Biomolecular Structure and Dynamics·2025· 2 cited
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
The Lancet Public Health·2025· 36 citedOpen Access
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet Infectious Diseases·2024· 111 citedOpen Access
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
The Lancet·2024· 238 citedOpen Access
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
The Lancet·2024· 2.2k citedOpen Access
Flurbiprofen clubbed schiff's base derivatives as potent anticancer agents: In Vitro and In Silico approach towards breast cancer
Journal of Molecular Structure·2024· 22 cited
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase
Current Medicinal Chemistry·2024· 3 cited
Identification of novel compounds and repurposing of FDA drugs for 1-deoxy-D-xylulose 5-phosphate reductoisomerase enzyme of Plasmodium falciparum to combat malaria resistance
International Journal of Biological Macromolecules·2023· 2 cited
Targeted vaccine development against Bilophila wadsworthia to curb colon diseases: A multiepitope approach based on reverse vaccinology and computational analysis
International Journal of Biological Macromolecules·2023· 10 cited
Structure-based identification of potential substrate antagonists for isethionate sulfite-lyase enzyme of Bilophila Wadsworthia: Towards novel therapeutic intervention to curb gut-associated illness
International Journal of Biological Macromolecules·2023· 6 cited
Bioinformatics and immunoinformatics approach to develop potent multi-peptide vaccine for coxsackievirus B3 capable of eliciting cellular and humoral immune response
International Journal of Biological Macromolecules·2023· 18 cited
page 1 of 2Next →

Frequent Co-authors

Muhammad Waqas(12), Jalal Arabloo(11), Ayman Ahmed(10), Isaac Yeboah Addo(9), Syed Shujait Ali(9), Ahmed Al‐Harrasi(9), Sobia Ahsan Halim(9), Richard Gyan Aboagye(8), Aqeel Ahmad(8), Demelash Areda(8), Seyyed Shamsadin Athari(8), Ahmed Abu‐Zaid(7), Haroon Ahmed(7), Syed Anees Ahmed(7), Awais Altaf(7), Aleksandr Y. Aravkin(7), Mohammad Al‐Wardat(7), Mohammad‐Mahdi Bastan(7), Sonu Bhaskar(7), Mohammed ALBashtawy(7)